Keywords: Inflammation, Preclinical
We report a novel nitric oxide (NO)-sensitive MRI contrast agent that holds potential for detecting endogenous NO. Type I collagen and HEK cell lysate showed strong binding with NO agent, while HSA and various ROS/RNS species showed NO agent was only activated by NO. In vivo washout rate was also tested, and NO agent cleared from mice 7 days after intraperitoneal injection. Prolonged enhancement was observed in the heart after isoproterenol injection, which indicated excess NO production and inflammation. The NO agent shows promise as a molecular imaging agent in early detection of inflammatory diseases.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords